Current position:Home >Product >
5-Methyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid
5-Methyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid(332851-36-2)
- Name: 5-Methyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid
- Synonyms:332851-36-2;5-methyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid;5-Methyl-7-trifluoromethyl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid;MFCD01922301;5-methyl-7-(trifluoromethyl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid;JFGKFJKTUKPTOO-UHFFFAOYSA-N;SMR000123152;TimTec1_007002;MLS000523174;SCHEMBL4878215;CHEMBL1498704;HMS1553O06;HMS2418K05;AKOS000301550;AKOS016345017;CCG-202975;LS-06422;EN300-83649;AK-968/15359162;SR-01000436587;SR-01000436587-1;5-methyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylicacid;5-Methyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid, AldrichCPR
- Molecular Formula:C9H10F3N3O2
- Molecular Weight:249.19
- CAS Registry Number:332851-36-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.332851-36-2 5-METHYL-7-TRIFLUOROMETHYL-4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLIC ACID
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] 
Premium
SupplierTel:+86-571-87396432
Address:No.200 Zhenhua Rd.Xihu Industrial Park, Hangzhou 310030, China
- Contact Suppliers
Other Product
- 348112-92-5/Tetrahydro-2H-pyrazino[1,2-A]pyrimidine-4,7(3H,6H)-dione
- 332404-37-2/2-(((e)-1,3-Benzodioxol-5-ylmethylidene)amino)-4,5-dimethyl-3-furonitrile
- 303215-67-0/2-{[(4-Anilinophenyl)imino]methyl}-4,6-dichlorophenol
- 310451-87-7/3-(4-Chloro-3-methylphenoxy)-5-nitroaniline
- 33963-44-9/3,4-Dichloro-5-methylbenzene-1,2-diol
- 321883-39-0/Sodium (2S,8R,19Z,22Z)-2-azaniumyl-8-{[(9Z,12Z)-octadeca-9,12-dienoyl]oxy}-5-oxido-5,11-dioxo-4,6,10-trioxa-5lambda~5~-phosphaoctacosa-19,22-dien-1-oate
- 338410-19-8/(2E)-3-amino-2-cyano-N-methyl-3-[4-(pyridin-2-yl)piperazin-1-yl]prop-2-enethioamide
- 321883-53-8/Sodium (2R)-2,3-bis(hexanoyloxy)propyl hydrogen phosphate
- 332412-74-5/5-(1-Phenylethylsulfanyl)-[1,3,4]thiadiazol-2-ylamine
- 338410-31-4/[5-({[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]-amino}methyl)-4,5-dihydro-3-isoxazolyl]methanol
- 338410-33-6/N'-(6-chloro-2-pyridinyl)-2-(2-nitroethyl)benzenecarbohydrazide
- 348133-47-1/2-chloro-6-fluoro-1-methyl-1H-benzo[d]imidazole
- 303729-54-6/1-(4-Isobutoxy-benzoyl)-pyrrolidine-2-carboxylic acid
- 338410-35-8/N-(4-chlorophenyl)-N'-[2-(2-nitroethyl)phenyl]urea
- 314764-11-9/N-[4-(Piperidine-1-sulfonyl)-phenyl]-succinamic acid
- 338411-65-7/2-Chloro-1-(5-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]methyl}-2-thienyl)-1-ethanone
- 332849-43-1/(3-Benzyl-2,5-dioxo-pyrrolidin-1-yl)-acetic acid
- 310466-20-7/2-(4-Phenylphenyl)acetamidine
- 332849-48-6/[3-(4-Chloro-benzyl)-2,5-dioxo-pyrrolidin-1-yl]-acetic acid
- 332851-36-2/5-Methyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid
- 386229-70-5/hexapotassium;[(2R,3R,4S,5R,6R)-2-[(2S,3S,4R,5R)-3,4-disulfonatooxy-2,5-bis(sulfonatooxymethyl)oxolan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-3-sulfonatooxyoxan-4-yl] sulfate
- 397845-86-2/4-Oxo-4-{[(1-phenylcyclopentyl)methyl]amino}-butanoic acid
- 310873-31-5/4-bromo-N-(5-chloro-2-methylphenyl)benzamide
- 310873-65-5/4-bromo-N-(3-chloro-2-methylphenyl)benzamide
- 332867-69-3/4-(5-(3-nitrophenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)-4-oxobutanoic acid
- 37454-84-5/2,5-Dioxopyrrolidine-1-carbothioamide
- 30343-27-2/3-(2-Fluorophenoxy)-2-butanone
- 338412-96-7/3-Chloro-4-[2,6-dinitro-4-(trifluoromethyl)phenoxy]aniline
- 30343-33-0/3-(4-Chloro-2-methylphenoxy)butan-2-one
- 338413-13-1/3-Chloro-4-(2-pyrimidinyloxy)phenylamine